A B S T R A C T Two
A B S T R A C T Two routes have been proposed for conversion of bilirubin monoglucuronide to the diglucuronide: glucuronyl transfer (a) from UDP-glucuronic acid to bilirubin monoglucuronide, catalyzed by a microsomal UDP-glucuronyltransferase, and (b) from one molecule of bilirubin monoglucuronide to another (transglucuronidation), catalyzed by an enzyme present in liver plasma membranes. The evidence regarding the role of the latter enzyme for in vivo formation of bilirubin diglucuronide is conflicting. We therefore decided to reexamine the transglucuronidation reaction in plasma membranes and to study the conversion of bilirubin monoglucuronide to diglucuronide in vivo. Purified bilirubin monoglucuronide was incubated with homogenates and plasma membrane-enriched fractions from liver of Wistar and Gunn rats. Stoichiometric formation of bilirubin and bilirubin diglucuronide out of 2 mol of bilirubin monoglucuronide was paralleled by an increase of the lIla-and XIIIaisomers of the bilirubin aglycone, thus showing that dipyrrole exchange, not transglucuronidation, is the underlying mechanism. Complete inhibition by ascorbic acid probably reflects intermediate formation of free radicals of dipyrrolic moieties. The reaction was nonenzymic because it proceeded independently of the protein concentration and heat denaturation of the plasma membranes did not result in decreased conversion rates. Collectively, these findings show spontaneous, nonenzymic dipyrrole exchange when bilirubin monoglucuronide is incubated in the presence of rat liver plasma membranes. Because bilirubin glucuronides present in biological fluids contain exclusively the bilirubin-IXa aglycone, formation of the diglu-
INTRODUCTION
In healthy humans and rats, bilirubin is converted mainly to glucuronides and excreted in bile as monoglucuronide (BMG,1 a mixture of two positional isomers, Fig. 1 ) and, predominantly, as the diglucuronide (BDG) (1) (2) (3) (4) (5) . The first metabolic conversion step involves transfer of a glucuronyl residue from UDP-glucuronic acid to bilirubin, catalyzed by a microsomal UDP-glucuronyltransferase (EC 2.4.1.17) (6) (7) (8) (9) .
Microsomal preparations from rat liver also catalyze UDP-glucuronic acid-dependent conjugation of BMG to form BDG (10, 11) and it is reasonable to assume that in vivo the same process is responsible, at least in part, for synthesis of BDG. As an alternative route, formation of BDG according to the disproportionation reaction 2 BMG = B + BDG (Eq. 1) has been proposed recently (12) (13) (14) . This transformation occurs in presence of plasma membrane-enriched preparations from rat liver (optimal pH 6.6) and has been claimed to be enzymic (12) , but its mechanism is uncertain (14) .
Conceivably, transfer of glucuronyl residues between 'Abbreviations used in this paper: B, unconjugated bilirubin irrespective of the isomeric structure, BMG, bilirubin monoglucuronide, BDG, bilirubin diglucuronide, HPLC, high-performance liquid chromatography, N2-fraction, plasma membrane-enriched subcellular fraction, TLC, thinlayer chromatography.
BMG molecules (transglucuronidation) (12) or dissociation into dipyrrole moieties and statistical recombination (dipyrrole exchange) could be involved (15, 16) . The postulated enzyme has been named bilirubin glucuronoside glucuronyltransferase (EC 2.4.1.95) (13) .
The hypothesis that UDP-glucuronic acid-independent transformation of BMG into BDG plays a role in synthesis of BDG in vivo (12) (13) (14) could not be confirmed by extensive analysis of biliary bile pigments formed in normal rat after injection of doubly-labeled BMG (17) , but contradictory evidence has been communicated in a preliminary report (18) . The homozygous Gunn rat offers a unique opportunity to test this hypothesis. Although this species congenitally lacks the ability to synthesize BMG from bilirubin (19, 20) , conversion of BMG to BDG and bilirubin (eqn. 1) is reported to occur at comparable rates in presence of plasma membrane-enriched fractions from liver of either Gunn rats or Wistar rats (12, 13) . In Gunn rats kept in darkness, unconjugated bilirubin is virtually not excreted into bile (21, 22) and is mainly metabolized to compounds that do not contain the bilirubin skeleton (23) . Therefore, the biliary content of bile pigments with the IXa-skeleton is very low (21, 22) and secretion studies with BMG can be done with unlabeled material. Again, in vivo studies in this species supporting (13, .14) and disproving (17) UDP-glucuronic acid-independent conversion of BMG into BDG have been published.
In view of the present confusion in this area, we decided to reassess the UDP-glucuronic acid-independent conversion of BMG to BDG (eqn. 1), both in vitro and in vivo. As it seemed likely that some of the contradictory results have arisen from the pronounced instability of BMG (autoxidation and nonenzymic dipyrrole exchange) we (24) . Bile samples (diluted 21-fold with glycine-HCl buffer pH 2.7) were mixed with diazo-reagent and diazo-cleavage was allowed to proceed for 30 min at pH 2.7 at 20-25-C (24, 25) . Under these conditions, reaction of BDG and BMG is complete and yields, respectively, azodipyrrole glucuronide (from BDG) and an equimolecular mixture of azodipyrrole and azodipyrrole glucuronide (from BMG). Reaction of unconjugated bilirubin is negligible if diazo-cleavage is performed at pH lower than or equal to 2.7 (24) . The total azo color derived from a given sample then is a measure of the total amount of bilirubin conjugates. It is essential to buffer the sample first to pH 2.7 before adding the diazo-reagent, because otherwise the reaction mixture may temporarily be at pH above 3, causing diazocleavage of unconjugated bilirubin (24) . Also, for bile, appropriate dilution (20-fold or more) is required because otherwise added or endogenous bilirubin may react to a considerable extent (26) , probably owing to the reactionpromoting effect of bile salts. By subsequent TLC of the azopigment extracts (25) , unconjugated azodipyrrole was separated from azodipyrrole glucuronide and the ratio: r = unconjugated azodipyrrole/azodipyrrole glucuronide (Eq.
2) was determined by densitometry (25) . The conjugates injected contained no conjugating groups other than glucuronic acid. Because reaction of BMG and BDG was complete, the azodipyrrole glucuronide formed thus reflects the total amount of conjugating groups. On the other hand, because only BMG contributed significantly to the unconjugated azodipyrrole formed, the proportion R of glucuronides could be calculated from the formula: R = BMG/(BMG + BDG) = 2r/(1 + r) (Eq. 3). In addition, the relative amounts of tetrapyrroles were determined by the alkaline methanolysis-TLC procedure of Blanckaert (5).
Immediately before and after infusion of BMG a 100-,1 sample of the pigment solution was analyzed without delay by the same methods as the bile samples. The molecular ratio of ethyl anthranilate diazonium salt to ascorbic acid exceeded 30, resulting in complete diazo-cleavage. For calculation of the output of injected BMG, the samples obtained during the control and injection periods were diluted 21- fold. The azo color obtained for the control samples amounted to <2% of the values found after injection of BMG. This small correction was applied to calculate the output of BMG. TLC of the azo pigment extracts from control bile samples showed negligible amounts of unconjugated azodipyrrole.
Experiments in vitro. Male Gunn (jj) and Wistar rats (300-450 g body wt) were fasted for 16 h with water ad lib. The animals were killed by cervical dislocation, their livers were perfused, homogenized, and fractionated according to the procedure of Touster et al. (27) . The plasma membraneenriched fraction, N2, present at the 7.5-37.2% (wt/wt) interphase in a discontinuous sucrose gradient, was identified by its marker enzyme activities and electron microscopy. The activities of 5'-nucleotidase and glucose-6-phosphatase were determined according to Weaver and Boyle (28), phospholipids by the method of Bartlett (29) after extraction according to Folch et al. (30) , and protein according to Peterson (31) . Electron microscopy was performed as described by Touster et al. (27) . The fractions were stored at 40C for no longer than 3 d.
Two incubation systems were used. Incubation system A (12): 1.25 ml of 25% liver homogenate (wt/vol) or N2 fraction (Fig. 3a) . Confirming the work of Jansen et al. (12) glucaro-1,4-lactone inhibited hydrolysis over the first 3-4 min (Fig. 4b) (12, 16) in the diazo-method (24, 25) , (b) to methanol containing 60 mM ascorbic acid (15) in the alkaline methanolysis procedures (34, 35) , and (c) to a strongly alkaline medium containing 60 mM ascorbic acid (15) Touster et al. (27) . Electron microscopic examination of N2-fractions from Gunn and Wistar rat liver revealed primarily smooth membranes without ribosomes. A few gap junctions (arrows in Fig. 5 ) could be clearly observed.
During incubation of plasma membrane-enriched N2 fractions from Gunn rat liver (incubation system A) with BMG the total bilirubin content was stable over the first 8 min, with only 3% color being lost after 16 min (Fig. 3a) . In contrast, total conjugates as measured by the ethyl anthranilate method (Fig. 3a) decreased steadily, the loss of total conjugates after 16 min amounting to 35%. The reaction was accompanied by an approximately parallel decrease of the ratio r (Fig. 3b) . Comparison of the amounts of bilirubin and BDG produced showed stoichiometric disproportionation of BMG (Eq. 1) up to 3-4 min (Fig. 4a) . The reaction was paralleled by an increase of the IIIa-and XIIIa-isomers of the bilirubin aglycone (Table I) proving exchange of dipyrrole moieties. Ascorbic acid (1 mM) completely inhibited formation of BDG from BMG (Fig. 4b) and exchange of dipyrrole moieties (Table I ) over the first 8 min. Exactly similar observations were made for Wistar rat liver (Table II) . Dipyrrole exchange was confirmed by the more direct alkaline methanolysis-HPLC procedure (Table III) .
Incubation of liver homogenates from Wistar and Gunn rats with BMG at pH 6.5 resulted in formation of BDG with a conversion rate of 4.1 and 21 nmol/ mg protein per min compared to 47±9 (SD, n = 4) for N2-fractions (incubation system A). As for the N2-fractions, dipyrrole exchange was confirmed by azopigment analysis and simultaneous analysis of the bilirubin a-isomers. Again, addition of ascorbic acid (final concentration 1 mM) to the incubation mixtures resulted in complete inhibition of the reaction. Incubation of 100-206 MM BMG with N2-fractions from Gunn rat liver (0-427 ,ug protein/ml) and from Wistar rat liver (0-613 Mg protein/ml) did not show the linear increase of the conversion rate expected for BMG (173 AM) was incubated with N2-fractions from Wistar rat liver at 37°C and pH 6.6 in incubation system B. At the indicated time intervals samples were removed and subjected to the alkaline methanolysis-HPLC procedure. Experiment a was done with 'natural' N2-fraction; in experiment b N2-fraction was heated for 10 min at 100°C before preparing the incubation mixture.
a catalyzed reaction (Fig. 6 ). If anything, the data suggested slight inhibition of the spontaneous rate of conversion by the added membrane material. Also, -heating the N2-fractions for 10 min at 100°C did not affect the rat of BDG formation for material from Wistar rat liver and was stimulatory with preparations from Gunn rat liver (Table IV) . Stability of BMG. To define conditions suitable for injecting BMG, the stability of the pigment was investigated in aqueous solutions at pH 7.4 (Table V) . Within 2 h the total concentration of conjugates decreased by 21% with a concomitant decrease of the r values. Close agreement was found with r values calculated on the assumption that the change involves disproportionation of BMG. In contrast, in presence of 1 mM sodium ascorbate at pH 7.4 and 25°C only 5% of BMG was lost after 2 h.
In vivo experiments. Two BMG preparations containing 0 and 2% of BDG, respectively, were dissolved in phosphate buffer containing ascorbic acid and injected in individual Gunn rats. Rapid excretion resulted, more than 95% of bilirubin conjugates being recovered in bile after 40 min. As shown by both azo pigment analysis and alkaline methanolysis, no BDG was formed from BMG either during the infusion or the passage of BMG through the liver (Table VI) .
Similar activity has been detected in Gunn rat liver (13) . In contrast, in the present work, spontaneous disproportionation of BMG (Eq. 1) at pH 6.6 was not enhanced by addition of N2 fractions from liver of either Gunn rats or Wistar rats (Fig. 6 ), as would be expected for a catalytic reaction. Also, inactivation of the postulated enzyme by heating either had little effect on the reaction rates or produced some increase (Table IV) . Slight inhibition of the reaction by added membrane material (Fig. 6) suggests that the rather low rates observed with liver homogenates could be (12) . On the other hand, it is possible that in the incubation system used by Gordon and Goresky (11) the IXa-structure of bilirubin was stabilized so that no nonenzymic processes were observed. The mechanism of the observed conversion has been described as sugar transfer (transglucuronidation) from one mole of BMG to another (12) . From our results a transglucuronidation mechanism can clearly be ruled out. Stoichiometric formation of BDG and bilirubin out of 2 mol of BMG was paralleled by a decrease of IXa-isomers and an increase of the IIIa-and XIIIaisomers. The evidence given in support of a transglucuronidation mechanism (12) appears to be unconvincing. Not the initial isomeric composition of the BMG preparation tested by Jansen et al. (12) , but only differences in composition found before and after incubation were reported. Therefore, it is impossible to know how closely the isomeric composition of the bilirubin aglycone of the BMG preparation used approached the equilibrium state (1:2:1). Perhaps more importantly, the incubation periods used were rather short (3 min) and probably were insufficient for significant enrichment in IIIa-and XIIIa-isomers, leading the authors to postulate that transglucuronidation must underly the observed disproportionation reaction. In the present work, both the disproportionation reaction and the formation of bilirubin-IlIa and -XIIIa isomers were inhibited completely by the free-radical scavenger, ascorbic acid (15) during incubation of BMG with liver homogenate or plasma membrane-enriched N2 fractions. Therefore, the underlying reaction mechanism is dipyrrole exchange proceeding probably via formation of free radicals.
It is questionable whether the UDP-glucuronic acidindependent formation of BDG plays any role in vivo. The data in support of the transglucuronidation hypothesis (12) on one hand are not convincing. On the other hand, BDG formation by nonenzymic dipyrrole exchange, as was shown by the present study in vitro, must be insignificant in vivo, because unconjugated and conjugated bilirubins present in biological fluids show nearly exclusively the IXa-isomeric structure (15) . Our in vivo studies confirm the observation of Blanckaert et al. (17) that in Gunn rats formation of BDG from BMG does not occur and lend support to the conclusion that UDP-glucuronic acid-dependent synthesis of BDG, which has been validated experimentally (10) , is the only plausible pathway of in vivo formation of BDG. The discrepancy of our in vivo results of those to other authors (13, 14) is as yet unexplained.
The conclusions from the present work are in sharp contradiction with those of other authors (12) (13) (14) . Although it is conceivable that both our Wistar and homozygous Gunn rats are deficient in bilirubin glucu- ronoside glucuronyltransferase, such an explanation seems highly unlikely. It is suggested that some unsuspected technical failure in the approach(es) used by the proponents of the transglucuronidase hypothesis (12) (13) (14) is at the basis of the discrepant results. It should be emphasized that the pronounced lability of bilirubin conjugates, in particular of BMG, may easily give rise to artifacts and lead to erroneous conclusions. Some of these problems can be overcome by taking advantage of the stabilizing effect of ascorbic acid (Table V) .
